About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Maryland | 690 Studies

Clinical Trials Prostate CancerMaryland

Prostate Cancer Clinical Trials in Maryland

Find 690 clinical trials for prostate cancer near Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 481-500 of 690 trials

RecruitingProfiling of Radiological Factors in Treatment and Outcomes in Prostate CancerBackground: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer.NCT03354416·Bethesda, Maryland TerminatedA 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate CancerA Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients.NCT01709734·Los Angeles, California and 22 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedMobile Sensor Technologies to Assess General Symptomology of People With CancerBackground: Many digital devices, such as smartphones and activity monitors, have sensors to collect and track health data.NCT04465214·Bethesda, Maryland

CompletedHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT01546987·Birmingham, Alabama and 171 others

CompletedTreatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy VaccinesBackground: Metastatic castration resistant prostate cancer (mCRPC) keeps growing even when the amount of testosterone in the body is reduced to very low levels. mCRPC is…NCT03481816·Bethesda, Maryland

TerminatedMGC018 With or Without MGA012 in Advanced Solid TumorsThe purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) pharmacodynamics and preliminary antitumor activity of vobramitamab duocarmazine…NCT03729596·Santa Monica, California and 20 others

CompletedA Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesTo evaluate the safety, tolerability, efficacy, and pharmacokinetics of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer…NCT00441337·Baltimore, Maryland and 3 others

CompletedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer.NCT00002602·Birmingham, Alabama and 227 others

CompletedStudy of TAS3681 in Metastatic Castration Resistant Prostate CancerThe purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3681 (Escalation Phase) and to…NCT02566772·Sacramento, California and 32 others

CompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerThe purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to…NCT03085095·Tucson, Arizona and 161 others

Active not recruitingPivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate CancerA prospective, multi-center, single-arm study, planned in 150 patients.NCT02766543·Los Angeles, California and 13 others

CompletedEvaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate CancerThis research is being done to see if an investigational radioactive drug called 18F-DCFBC can help us find cancer that has spread (metastatic disease) from its original site in…NCT01815515·Baltimore, Maryland

CompletedExternal-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells.NCT00006365·Birmingham, Alabama and 253 others

RecruitingPatient Navigation Program to Improve Clinical Trial Enrollment in Cancer PatientsThe goal of this clinical trial is to test the utility of patient navigation by comparing high intensity patient navigation to low intensity navigation approaches to improving…NCT06138067·Baltimore, Maryland and 1 other

CompletedStudy to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseThe purpose of this study is to determine the effect of AZD0530 on subjects with breast cancer or prostate cancer with metastatic bone disease in comparison to zoledronic acid.NCT00558272·Pleasant Hill, California and 27 others

Completed3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical ProstatectomyIn April 2011, the United States Food and Drug Administration (FDA) approved the oral drug abiraterone acetate (Zytiga ®) in combination with prednisone (a steroid) to treat…NCT01751451·Chicago, Illinois and 15 others

CompletedA Study of Definitive Therapy to Treat Prostate CancerTo assess the safety of treating men with oligometastatic prostate cancer with the following therapy: (1st) Systemic chemo-hormonal therapy with up to 6-months (\~24 weeks) of…NCT02716974·Washington D.C., District of Columbia and 2 others

CompletedA Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal TherapyThis research is being done to test an investigational drug, called itraconazole, in the treatment of prostate cancer.NCT00887458·Baltimore, Maryland and 3 others

CompletedObservational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerThis is a single-arm observational longitudinal study in of patients with metastatic castrate-resistant prostate cancer designed to assess the longitudinal trajectory of pain and…NCT02008058·Baltimore, Maryland and 3 others

RecruitingTrial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate CancerTo determine if dexamethasone or dexamethasone plus metronidazole restore sensitivity to abiraterone for the treatment of metastatic prostate cancer.NCT06616597·Baltimore, Maryland

PreviousPage 25 of 35Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma